An international, randomized, double-blind, placebo-controlled,phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia

Journal of Rheumatology

Volumn 38, Issue 12, 2011, Pages 2643-2652

  Pauer, Lynne ^a,b,c,d,e,f   Winkelmann, Andreas ^a,b,c,d,e,f   Arsenault, Pierre ^a,b,c,d,e,f   Jespersen, Anders ^a,b,c,d,e,f   Whelan, Laurence ^a,b,c,d,e,f   Atkinson, Gary ^a,b,c,d,e,f   Leon, Teresa ^a,b,c,d,e,f   Zeiher, Bernhardt ^a,b,c,d,e,f  

^a PFIZER INC   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Diex Research Inc   (Canada)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^f Pfizer Global Pharmaceuticals   (United States)

Author keywords

Fibromyalgia; Pain; Pregabalin; Rheumatology; Sleep

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOMES STUDY SLEEP SCALE SLEEP DISTURBANCE SUBSCALE; MONOTHERAPY; PAIN ASSESSMENT; PATIENT GLOBAL IMPRESSION OF CHANGE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP QUALITY; SLEEP QUALITY DIARY; SOMNOLENCE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PLACEBOS; QUESTIONNAIRES; SLEEP; SLEEP DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 82755162857     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110569     Document Type: Article

References (41)

1. Bennett RM. Fibromyalgia. In: Wall PD, Melzack R, eds. Textbook of pain. 4th ed. London: Harcourt Publishers, Churchill Livingstone; 1999:579-601.
2. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685-701.
3. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005 Aug;75:6-21. (Pubitemid 41113954)
4. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72. (Pubitemid 20098653)
5. Bannwarth B, Blotman F, Thomas E. Prevalence of fibromyalgia: a large-scale European survey: results in France [abstract]. Ann Rheum Dis 2008;67:259.
6. Roué-Le Lay K, Boussetta S, Caubére J. Prevalence of fibromyalgia: early results in United Kingdom [abstract]. Ann Rheum Dis 2008;67:259.
7. Spaeth M, Roué-Le Lay K, Boussetta S. Prevalence of fibromyalgia: a large-scale European survey: results in Germany [abstract]. Ann Rheum Dis 2008;67:259.
8. Assumpcão A, Cavalcante AB, Sauer JF. Prevalence of fibromyalgia and main symptoms assessment in the health care system population of Embu, Sao Paolo, Brazil [abstract]. Ann Rheum Dis 2007;66:653.
9. Branco JC, Caubére J, André E. Prevalence of fibromyalgia in Portugal: updated results [abstract]. Ann Rheum Dis 2007;66:426.
10. Carbonell J, Caubére J, André E. Prevalence of fibromyalgia in Spain: updated results [abstract]. Ann Rheum Dis 2007;66:426.
11. Cardiel MH, Rojas-Serrano J. Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study. Clin Exp Rheumatol 2002;20:617-24. (Pubitemid 35243773)
12. Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 2005;32:348-53. (Pubitemid 40209136)
13. Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrström P. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 2000;18:149-53.
14. Matucci CM, Zoppi M, André E. Prevalence of fibromyalgia in Italy: updated results [abstract]. Ann Rheum Dis 2007;66:427.
15. Nasonov EL, Soldatov D, Roué-Le Lay K. Prevalence of fibromyalgia: early results in Russia [abstract]. Ann Rheum Dis 2008;67:259.
16. Prescott E, Kjøller M, Jacobsen S, Bülow PM, Danneskiold-Samsøe B, Kamper-Jørgensen F. Fibromyalgia in the adult Danish population: I. A prevalence study. Scand J Rheumatol 1993;22:233-7. (Pubitemid 23311153)
17. Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004;31:594-7. (Pubitemid 38337624)
18. Toda K. The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol 2007;36:140-4. (Pubitemid 46685764)
19. Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 2005;34:140-4. (Pubitemid 40694834)
20. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999;26:1570-6. (Pubitemid 29317882)
21. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
22. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 2008;67:536-41. (Pubitemid 351498437)
23. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, et al. Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 2008;59:952-60. (Pubitemid 351990991)
24. Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, et al. Identification of the a2-d-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci USA 2006;103:17537-42. (Pubitemid 44789004)
25. Crofford LJ, Mease PJ, Simpson SL, Young JP Jr, Martin SA, Haig GM, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain 2008;136:419-31.
26. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al.; Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73. (Pubitemid 40530135)
27. Mease PJ, Russell IJ, Arnold LM, Florian H, Young JP Jr, Martin SA, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 2008;35:502-14. (Pubitemid 351374429)
28. Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, et al. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain 2008;9:792-805.
29. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-7. (Pubitemid 18029372)
30. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105-21. (Pubitemid 351147828)
31. Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58. (Pubitemid 33016608)
32. Guy W. ECDEU assessment manual for psychopharmacology (DHEW Publication No. ADM 76-338). Washington, DC: U.S. Government Printing Office; 1976.
33. Hays RD, Stewart AL. Sleep measures. In: Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being. Durham, NC: Duke University Press; 1992:235-9.
34. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728-33.
35. Cappelleri JC, Bushmakin AG, McDermott AM, Sadosky AB, Petrie CD, Martin S. Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia. Health Qual Life Outcomes 2009;7:54.
36. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale manual. London: NFER Nelson; 1994.
37. Steel R, Torrie J. Principles and procedures of statistics. New York: McGraw-Hill; 1960.
38. Berry D. Statistical methodology in the pharmaceutical sciences. New York: Marcel Dekker; 1990.
39. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
40. Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 2007;8:27.
41. Cook RJ, Sackett DL. The number needed to treat: A clinically useful measure of treatment effect. BMJ 1995;310:452-4.